Clinical Translation of Stem Cell Therapies: A Bridgeable Gap

被引:40
作者
Cuende, Natividad [1 ]
Izeta, Ander [2 ]
机构
[1] Andalusian Initiat Adv Therapies, Seville 41101, Spain
[2] Hosp Donostia, Inst Biodonostia, San Sebastian 20014, Spain
关键词
D O I
10.1016/j.stem.2010.05.005
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Stem cell scientists trying to reach patients often lack the multidisciplinary skills needed to overcome complex regulatory barriers and may feel deterred from pursuing clinical implementation. In order to help bridge this gap, we offer a European perspective based on our hands-on experience at the Andalusian Initiative for Advanced Therapies.
引用
收藏
页码:508 / 512
页数:5
相关论文
共 11 条
[1]   Isolation and Production of Cells Suitable for Human Therapy: Challenges Ahead [J].
Ahrlund-Richter, Lars ;
De Luca, Michele ;
Marshak, Daniel R. ;
Munsie, Megan ;
Veiga, Anna ;
Rao, Mahendra .
CELL STEM CELL, 2009, 4 (01) :20-26
[2]  
Aiuti Alessandro, 2009, Hematology Am Soc Hematol Educ Program, P682, DOI 10.1182/asheducation-2009.1.682
[3]   Stem cells: roadmap to the clinic [J].
Daley, George Q. .
JOURNAL OF CLINICAL INVESTIGATION, 2010, 120 (01) :8-10
[4]   Stem cell therapy delivery: treading the regulatory tightrope [J].
Daniels, Julie T. ;
Secker, Genevieve A. ;
Shortt, Alex J. ;
Tuft, Stephen J. ;
Seetharaman, Sbankar .
REGENERATIVE MEDICINE, 2006, 1 (05) :715-719
[5]   New ISSCR Guidelines Underscore Major Principles for Responsible Translational Stem Cell Research [J].
Hyun, Insoo ;
Lindvall, Olle ;
Ahrlund-Richter, Lars ;
Cattaneo, Elena ;
Cavazzana-Calvo, Marina ;
Cossu, Giulio ;
De Luca, Michele ;
Fox, Ira J. ;
Gerstle, Claude ;
Goldstein, Robert A. ;
Hermeren, Goran ;
High, Katherine A. ;
Kim, Hyun Ok ;
Lee, Hin Peng ;
Levy-Lahad, Ephrat ;
Li, Lingsong ;
Lo, Bernard ;
Marshak, Daniel R. ;
McNab, Angela ;
Munsie, Megan ;
Nakauchi, Hiromitsu ;
Rao, Mahendra ;
Rooke, Heather M. ;
Valles, Carlos Simon ;
Srivastava, Alok ;
Sugarman, Jeremy ;
Taylor, Patrick L. ;
Veiga, Anna ;
Wong, Adrianne L. ;
Zoloth, Laurie ;
Daley, George Q. .
CELL STEM CELL, 2008, 3 (06) :607-609
[6]   Can the pharmaceutical industry reduce attrition rates? [J].
Kola, I ;
Landis, J .
NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (08) :711-715
[7]   Great expectations: Private sector activity in tissue engineering, regenerative medicine, and stem cell therapeutics [J].
Lysaght, Michael J. ;
Jaklenec, Ana ;
Deweerd, Elizabeth .
TISSUE ENGINEERING PART A, 2008, 14 (02) :305-U57
[8]   Pharma's Developing Interest in Stem Cells [J].
McKernan, Ruth ;
McNeish, John ;
Smith, Devyn .
CELL STEM CELL, 2010, 6 (06) :517-520
[9]   Developing a Case Study Model for Successful Translation of Stem Cell Therapies [J].
Trounson, Alan ;
Baum, Elona ;
Gibbons, Don ;
Tekamp-Olson, Patricia .
CELL STEM CELL, 2010, 6 (06) :513-516
[10]   ELIXIRS, DILUENTS, AND THE PASSAGE OF THE 1938 FEDERAL FOOD, DRUG AND COSMETIC ACT [J].
WAX, PM .
ANNALS OF INTERNAL MEDICINE, 1995, 122 (06) :456-461